Variant report

Variant	nsv976635
Chromosome Location	chr12:64215811-64218681
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:46)
CpG islands
(count:122)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:46 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr12:64217057-64217132	HepG2	liver:	n/a	chr12:64217070-64217081 chr12:64217072-64217083
2	CTCF	chr12:64216900-64217050	GM12878	blood:	n/a	n/a
3	CTCF	chr12:64216978-64217019	GM12891	blood:	n/a	n/a
4	CTCF	chr12:64216853-64217113	GM12878	blood:	n/a	n/a
5	CTCF	chr12:64216973-64217054	GM12892	blood:	n/a	n/a
6	CTCF	chr12:64216972-64217072	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr12:64216990-64217060	GM10266	blood:	n/a	n/a
8	CTCF	chr12:64216900-64217050	HEK293	kidney:	n/a	n/a
9	CTCF	chr12:64216984-64217050	Medullo	brain:	n/a	n/a
10	CTCF	chr12:64216949-64217048	NHEK	skin:	n/a	n/a
11	CTCF	chr12:64216974-64217026	MCF-7	breast:	n/a	n/a
12	CTCF	chr12:64216948-64217051	K562	blood:	n/a	n/a
13	CTCF	chr12:64216959-64217004	Gliobla	brain:	n/a	n/a
14	CTCF	chr12:64216877-64217092	H1-hESC	embryonic stem cell:	n/a	n/a
15	CTCF	chr12:64216920-64217101	GM12878	blood:	n/a	n/a
16	CTCF	chr12:64216927-64217037	Hela-S3	cervix:	n/a	n/a
17	CTCF	chr12:64218025-64218051	GM20000	blood:	n/a	n/a
18	CTCF	chr12:64216921-64217088	GM19238	blood:	n/a	n/a
19	FOS	chr12:64216261-64216529	MCF10A-Er-Src	breast:	n/a	n/a
20	FOS	chr12:64216260-64216535	MCF10A-Er-Src	breast:	n/a	n/a
21	FOS	chr12:64216274-64216524	MCF10A-Er-Src	breast:	n/a	n/a
22	FOS	chr12:64216298-64216568	MCF10A-Er-Src	breast:	n/a	n/a
23	FOXA1	chr12:64217006-64217305	HepG2	liver:	n/a	n/a
24	MYC	chr12:64218471-64218551	MCF10A-Er-Src	breast:	n/a	n/a
25	NRF1	chr12:64215516-64215838	GM12878	blood:	n/a	chr12:64215675-64215689 chr12:64215678-64215689 chr12:64215684-64215695
26	POLR2A	chr12:64216969-64217035	MCF-7	breast:	n/a	n/a
27	POLR2A	chr12:64216887-64217067	GM12878	blood:	n/a	n/a
28	POLR2A	chr12:64217063-64217096	MCF-7	breast:	n/a	n/a
29	POLR2A	chr12:64215589-64215940	ProgFib	skin:	n/a	n/a
30	POLR2A	chr12:64215888-64215889	A549	lung:	n/a	n/a
31	POLR2A	chr12:64215840-64215938	HepG2	liver:	n/a	n/a
32	POLR2A	chr12:64215868-64215884	A549	lung:	n/a	n/a
33	POLR2A	chr12:64215686-64215856	GM12878	blood:	n/a	n/a
34	POLR2A	chr12:64215953-64215965	A549	lung:	n/a	n/a
35	POLR2A	chr12:64215934-64215937	A549	lung:	n/a	n/a
36	POLR2A	chr12:64215818-64215912	Gliobla	brain:	n/a	n/a
37	POLR2A	chr12:64215547-64216043	GM12878	blood:	n/a	n/a
38	POLR2A	chr12:64215433-64215961	GM19193	blood:	n/a	n/a
39	RAD21	chr12:64216820-64217134	H1-hESC	embryonic stem cell:	n/a	n/a
40	RAD21	chr12:64216900-64217045	GM12878	blood:	n/a	n/a
41	RAD21	chr12:64216849-64217155	H1-hESC	embryonic stem cell:	n/a	n/a
42	RAD21	chr12:64216756-64217202	H1-hESC	embryonic stem cell:	n/a	n/a
43	SP1	chr12:64216912-64217125	H1-hESC	embryonic stem cell:	n/a	n/a
44	STAT3	chr12:64216252-64216548	MCF10A-Er-Src	breast:	n/a	n/a
45	STAT3	chr12:64216287-64216484	MCF10A-Er-Src	breast:	n/a	n/a
46	ZBTB33	chr12:64216919-64217320	K562	blood:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:64215897-64215947	HEEpiC	esophagus:	n/a
2	chr12:64216781-64216831	SKMC	muscle:	n/a
3	chr12:64216781-64216831	NB4	blood:	n/a
4	chr12:64215897-64215947	HL-60	blood:	n/a
5	chr12:64215897-64215947	ProgFib	skin:	n/a
6	chr12:64215897-64215947	SK-N-SH	brain:	n/a
7	chr12:64215897-64215947	ECC-1	luminal epithelium:	n/a
8	chr12:64216781-64216831	HRPEpiC	eye:	n/a
9	chr12:64215897-64215947	RPTEC	kidney:	n/a
10	chr12:64215897-64215947	SK-N-MC	brain:	n/a
11	chr12:64215897-64215947	ovcar-3	ovarian:	n/a
12	chr12:64215897-64215947	MCF10A-Er-Src	breast:	n/a
13	chr12:64215897-64215947	GM12878	blood:	n/a
14	chr12:64216781-64216831	MCF10A-Er-Src	breast:	n/a
15	chr12:64216781-64216831	CMK	blood:	n/a
16	chr12:64215897-64215947	NB4	blood:	n/a
17	chr12:64215897-64215947	HMEC	breast:	n/a
18	chr12:64216781-64216831	GM12892	blood:	n/a
19	chr12:64215897-64215947	A549	lung:	n/a
20	chr12:64215897-64215947	HNPCEpiC	eye:	n/a
21	chr12:64216781-64216831	PrEC	prostate:	n/a
22	chr12:64216781-64216831	NH-A	brain:	n/a
23	chr12:64215897-64215947	HRCEpiC	kidney:	n/a
24	chr12:64215897-64215947	PFSK-1	brain:	n/a
25	chr12:64216781-64216831	NHBE	bronchial:	n/a
26	chr12:64215897-64215947	Hepatocyte	liver:	n/a
27	chr12:64216781-64216831	SAEC	small airway:	n/a
28	chr12:64215897-64215947	GM06990	blood:	n/a
29	chr12:64216781-64216831	K562	blood:	n/a
30	chr12:64216781-64216831	NT2-D1	testis:	n/a
31	chr12:64216781-64216831	SK-N-SH	brain:	n/a
32	chr12:64216781-64216831	NHDF-neo	bronchial:	n/a
33	chr12:64216781-64216831	U87	brain:	n/a
34	chr12:64215897-64215947	AG10803	skin:	n/a
35	chr12:64216781-64216831	GM19239	blood:	n/a
36	chr12:64215897-64215947	HIPEpiC	eye:	n/a
37	chr12:64216781-64216831	MCF-7	breast:	n/a
38	chr12:64215897-64215947	NHDF-neo	bronchial:	n/a
39	chr12:64215897-64215947	PANC-1	pancreas:	n/a
40	chr12:64215897-64215947	BE2_C	brain:	n/a
41	chr12:64215897-64215947	SK-N-SH_RA	brain:	n/a
42	chr12:64216781-64216831	HEEpiC	esophagus:	n/a
43	chr12:64215897-64215947	HCT-116	colon:	n/a
44	chr12:64216781-64216831	T-47D	breast:	n/a
45	chr12:64215897-64215947	IMR90	lung:	fetal
46	chr12:64216781-64216831	HRE	kidney:	n/a
47	chr12:64216781-64216831	GM06990	blood:	n/a
48	chr12:64215897-64215947	H1-hESC	embryonic stem cell:	embryo
49	chr12:64216781-64216831	HRCEpiC	kidney:	n/a
50	chr12:64216781-64216831	H1-hESC	embryonic stem cell:	embryo

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr12:64217509..64221238-chr12:64626563..64629980,3	MCF-7	breast:

No data

Variant related genes	Relation type
TMEM5-AS1	TF binding region
TMEM5-AS1	CpG island

Extended variants
information (count: 127 )
Associated
traits (count: 82 )

Variant overlapped rSNPs/rCNVs (count:127 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs539787213	chr12:64215909-64215910	Enhancers Genic enhancers Active TSS Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs553113076	chr12:64215958-64215959	Enhancers Genic enhancers Active TSS Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs550567137	chr12:64215961-64215962	Enhancers Genic enhancers Active TSS Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs535175422	chr12:64215962-64215963	Enhancers Genic enhancers Active TSS Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs555456505	chr12:64216005-64216006	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs192928610	chr12:64216021-64216022	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs79012415	chr12:64216029-64216030	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs184767503	chr12:64216048-64216049	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs544174923	chr12:64216067-64216068	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs74804941	chr12:64216163-64216164	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs189577389	chr12:64216164-64216165	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs78928292	chr12:64216172-64216173	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs79918635	chr12:64216188-64216189	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs76560083	chr12:64216189-64216190	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs76415170	chr12:64216190-64216191	Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs80288519	chr12:64216203-64216204	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs79652788	chr12:64216221-64216222	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs77162414	chr12:64216227-64216228	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs77699321	chr12:64216236-64216237	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs74515707	chr12:64216237-64216238	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs540542050	chr12:64216246-64216247	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs560341631	chr12:64216247-64216248	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs74325498	chr12:64216257-64216258	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs369048335	chr12:64216263-64216264	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs529121676	chr12:64216277-64216278	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs78280451	chr12:64216290-64216291	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs570756061	chr12:64216293-64216294	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs562194379	chr12:64216347-64216348	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs539962640	chr12:64216349-64216350	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs137926648	chr12:64216354-64216355	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs570524727	chr12:64216357-64216358	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs539699906	chr12:64216408-64216409	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs546913128	chr12:64216411-64216412	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs566691508	chr12:64216453-64216454	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs370346043	chr12:64216460-64216461	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs555712883	chr12:64216486-64216487	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs575296298	chr12:64216524-64216525	Weak transcription Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs112555756	chr12:64216626-64216627	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs112160968	chr12:64216635-64216636	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs537585075	chr12:64216653-64216654	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs557746492	chr12:64216716-64216717	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs200235012	chr12:64216746-64216747	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs180706966	chr12:64216767-64216768	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs540505016	chr12:64216770-64216771	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs183759918	chr12:64216800-64216801	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
46	rs116361284	chr12:64216807-64216808	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
47	rs542783214	chr12:64216854-64216855	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs201687844	chr12:64216883-64216884	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs562586047	chr12:64216884-64216885	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs200027038	chr12:64216885-64216886	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:82)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Neurodevelopmental disorder	22521361	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lissencephaly	21572526	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16272173	CNVD
Glioblastoma multiforme	17387387	CNVD
liposarcomas	17372913	CNVD
Non-small cell lung cancer	24170126	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	21785460	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21390271	CNVD
Cancer	20164919	CNVD
Leukemia	18628472	CNVD
Phyllodes tumor	17334353	CNVD
Glaucoma	21310917	CNVD
Breast cancer	16272173	CNVD
Mental retardation	19951919	CNVD
Glaucoma	21447600	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Developmental delay	21267005	CNVD
12q14 microdeletion syndrome	21267005	CNVD
Developmental delay	19277063	CNVD
Dwarfism	19277063	CNVD
Fibroblasts	20926602	CNVD
Metanephric adenoma	20802469	CNVD
Follicular lymphoma	18703704	CNVD
Acute myeloid leukemia	21251322	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Multiple myeloma	16616336	CNVD
Lung cancer	16773561	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Mental retardation	17220210	CNVD
Osteopoikilosis	17220210	CNVD
short stature	17220210	CNVD
Burkitt''s lymphoma	20823134	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Heart disease	21282601	CNVD
Ovarian neoplasms	16753589	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	16620391	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:153 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:64215200-64216000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
2	chr12:64215200-64216000	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr12:64215200-64216400	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr12:64215200-64216400	Active TSS	Breast Myoepithelial Primary Cells	Breast
5	chr12:64215200-64216600	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
6	chr12:64215400-64216000	Active TSS	iPS-15b Cell Line	embryonic stem cell
7	chr12:64215400-64216000	Active TSS	Primary T cells from cord blood	blood
8	chr12:64215400-64216000	Bivalent/Poised TSS	Primary T cells fromperipheralblood	blood
9	chr12:64215400-64216000	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr12:64215400-64216000	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
11	chr12:64215400-64216000	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
12	chr12:64215400-64216000	Active TSS	Aorta	Aorta
13	chr12:64215400-64216000	Active TSS	Liver	Liver
14	chr12:64215400-64216000	Active TSS	Esophagus	oesophagus
15	chr12:64215400-64216000	Active TSS	Fetal Brain Female	brain
16	chr12:64215400-64216000	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
17	chr12:64215400-64216000	Bivalent/Poised TSS	Fetal Stomach	stomach
18	chr12:64215400-64216000	Active TSS	Right Atrium	heart
19	chr12:64215400-64216000	Active TSS	Skeletal Muscle Female	skeletal muscle
20	chr12:64215400-64216000	Active TSS	Thymus	Thymus
21	chr12:64215400-64216000	Active TSS	Osteobl	bone
22	chr12:64215400-64216200	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
23	chr12:64215400-64216200	Active TSS	Brain Hippocampus Middle	brain
24	chr12:64215400-64216200	Active TSS	Colon Smooth Muscle	Colon
25	chr12:64215400-64216200	Bivalent/Poised TSS	Fetal Adrenal Gland	Adrenal Gland
26	chr12:64215400-64216200	Bivalent/Poised TSS	Fetal Intestine Large	intestine
27	chr12:64215400-64216200	Bivalent/Poised TSS	Fetal Intestine Small	intestine
28	chr12:64215400-64216200	Active TSS	Fetal Kidney	kidney
29	chr12:64215400-64216200	Active TSS	Ovary	ovary
30	chr12:64215400-64216200	Active TSS	Rectal Smooth Muscle	rectum
31	chr12:64215400-64216400	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr12:64215400-64216400	Active TSS	Brain Anterior Caudate	brain
33	chr12:64215400-64216400	Active TSS	Duodenum Smooth Muscle	Duodenum
34	chr12:64215400-64216400	Active TSS	Pancreatic Islets	Pancreatic Islet
35	chr12:64215400-64216400	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
36	chr12:64215400-64216400	Active TSS	Stomach Smooth Muscle	stomach
37	chr12:64215400-64216400	Active TSS	NHLF	lung
38	chr12:64215400-64216600	Active TSS	Muscle Satellite Cultured Cells	--
39	chr12:64215400-64216600	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
40	chr12:64215400-64216800	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
41	chr12:64215400-64216800	Active TSS	Brain Substantia Nigra	brain
42	chr12:64215600-64216000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
43	chr12:64215600-64216000	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
44	chr12:64215600-64216000	Active TSS	HUES48 Cell Line	embryonic stem cell
45	chr12:64215600-64216000	Active TSS	HUES6 Cell Line	embryonic stem cell
46	chr12:64215600-64216000	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr12:64215600-64216000	Flanking Bivalent TSS/Enh	Primary monocytes fromperipheralblood	blood
48	chr12:64215600-64216000	Active TSS	Primary T helper 17 cells PMA-I stimulated	--
49	chr12:64215600-64216000	Active TSS	Primary Natural Killer cells fromperipheralblood	blood
50	chr12:64215600-64216000	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links